Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |